Scancell secures $6mn milestone from Genmab

Scancell Holdings (SCLP) has stayed largely under the radar since it joined Aim in 2010. Founded in 1997, the company was launched based on research into immunotherapy by the University of Nottingham and came through the early 2000s biotech bust in the UK unscathed.